We are live on ! Find out more
PSC

Patient Square Capital Portfolio holdings

AUM $564M
1-Year Est. Return 261.3%
This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+261.3%
3 Year Est. Return
+328.19%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$269M
AUM Growth
+$54M
Cap. Flow
+$58.5M
Cap. Flow %
21.72%
Top 10 Hldgs %
99.84%
Holding
11
New
9
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CGEM icon
Cullinan Oncology
CGEM
+$14.6M
2
INSM icon
Insmed
INSM
+$12.7M
3
EYPT icon
EyePoint Inc
EYPT
+$12M
4
NRIX icon
Nurix Therapeutics
NRIX
+$7.38M
5
PHVS icon
Pharvaris
PHVS
+$4.43M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ROIV icon
1
Roivant Sciences
ROIV
$24.1B
$141M 52.38%
12,228,465
– –
LQDA icon
2
Liquidia Corp
LQDA
$7.46B
$71.8M 26.66%
7,182,532
– –
CGEM icon
3
Cullinan Oncology
CGEM
$999M
$13.8M 5.12%
+824,705
New +$14.6M
INSM icon
4
Insmed
INSM
$21.3B
$12.5M 4.65%
+171,704
New +$12.7M
EYPT icon
5
EyePoint Inc
EYPT
$1.04B
$10.9M 4.04%
+1,361,979
New +$12M
NRIX icon
6
Nurix Therapeutics
NRIX
$2.41B
$7.32M 2.72%
+325,789
New +$7.38M
PHVS icon
7
Pharvaris
PHVS
$2.25B
$4.49M 1.67%
+242,341
New +$4.43M
NTLA icon
8
Intellia Therapeutics
NTLA
$1.5B
$2.64M 0.98%
+128,569
New +$2.96M
ELVN icon
9
Enliven Therapeutics
ELVN
$4.15B
$2.31M 0.86%
+90,572
New +$2.1M
OCUL icon
10
Ocular Therapeutix
OCUL
$1.84B
$2.05M 0.76%
+235,498
New +$1.94M
ATXS
11
DELISTED
Astria Therapeutics
ATXS
$434K 0.16%
+39,422
New +$438K

Similar funds

TCP
ThornTree Capital Partners Boston, Massachusetts $564M AUM 36.37% 1-Year Est. Return
AHSW
Adventist Health System West Roseville, California $564M AUM 17.1% 1-Year Est. Return
KF
KKM Financial Chicago, Illinois $563M AUM 28.2% 1-Year Est. Return
KBG
Kahn Brothers Group New York $564M AUM 25.3% 1-Year Est. Return
AAS
Asset Allocation Strategies Farmington, Michigan $563M AUM 15.65% 1-Year Est. Return
LC
Lavaca Capital Houston, Texas $564M AUM 4.6% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $565M AUM

Patient Square Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Patient Square Capital held 11 positions worth $269M, up 25% from $215M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Patient Square Capital deployed $58.5M of net new capital in Q3 2024, opening 9 new positions. Its largest new stake was Cullinan Oncology: 824,705 shares worth $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Patient Square Capital's largest Q3 2024 buy was Cullinan Oncology: 824,705 shares worth $13.8M.
  • Patient Square Capital's ten largest holdings make up 100% of its $269M portfolio in Q3 2024.
  • Patient Square Capital opened 9 new positions and closed 0 in Q3 2024.
  • Patient Square Capital's portfolio value rose 25% quarter-over-quarter to $269M.

Based on Patient Square Capital's 13F filing for Q3 2024, filed 14 Nov 2024.